Management of Indeterminate Dengue IgM (Trace) Results

Definition & Interpretation

A trace‑positive dengue IgM result is classified as indeterminate and must be followed by repeat IgM testing on the same specimen or a confirmatory plaque reduction neutralization test (PRNT) to achieve a definitive diagnosis. (CDC) 1
Indeterminate IgM results cannot differentiate true dengue infection from false‑positive findings or cross‑reactivity with other flaviviruses. (CDC) 1
Such results may represent an early antibody response that precedes full seroconversion. (CDC) 2

Repeat IgM testing on the original specimen or perform a confirmatory PRNT as the first step when an indeterminate IgM is encountered. (CDC) 1, 3
If repeat testing or PRNT is unavailable, obtain a second serum specimen for IgM testing. (CDC) 1, 4

Specimens collected ≤ 7 days after symptom onset – an indeterminate IgM often reflects collection before antibodies are detectable; therefore, nucleic acid amplification testing (NAAT) or NS1 antigen testing should be considered, and a negative acute IgM does not exclude infection in the absence of NAAT. (CDC) 2
Specimens collected > 7 days after symptom onset – IgM is usually reliably detectable in true infections; both dengue and Zika IgM should be performed because of cross‑reactivity, and a positive result on either test should be followed by PRNT for definitive diagnosis. (CDC) 2, 1

A PRNT titer ≥ 10 against dengue with negative titers (< 10) for Zika and other flaviviruses confirms a recent dengue infection. (CDC) 1, 3
A PRNT titer ≥ 10 for both dengue and Zika indicates a recent flavivirus infection but cannot specify which virus caused it. (CDC) 1, 5
Negative PRNT titers for both dengue and Zika in specimens collected > 7 days after onset effectively rule out recent infection with either virus. (CDC) 3

Cross‑reactivity with other flaviviruses (e.g., Zika, yellow fever, Japanese encephalitis) is common in endemic regions and can produce indeterminate IgM results. (CDC) 2
Interpretation should incorporate local circulation patterns of dengue serotypes and co‑circulating flaviviruses to assess pre‑test probability. (CDC) 2, 4
IgM antibodies may persist for months after infection; therefore, serology alone cannot pinpoint the timing of the infection. (CDC) 2, 7

Pregnant individuals – the same diagnostic algorithm applies, but prolonged IgM persistence limits timing determination; epidemiological and clinical data must be used to evaluate the likelihood of infection during pregnancy. (CDC) 7

All facts are drawn from CDC recommendations (MMWR Reports, 2019) and include the cited reference IDs.